The stock UNH has experienced a significant drop, trading at 282.26, down 19.76% today. This decline is attributed to several factors including the company's divestitures in international markets, a projected 2% year-over-year revenue decline for 2026, and a $6 billion revenue hit from Medicare's new coding system. The company is shifting focus to profitable growth in its US operations. While the current forward P/E ratio of 16.15 is considered low historically, suggesting potential undervaluation, the company's guidance and market headwinds indicate a bearish short-term outlook. The analysis suggests a potential price target of 250, with a stop-loss at 300.